Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.60 | N/A |
| PEG Ratio (TTM) | -0.53 | N/A |
| P/S Ratio (TTM) | 0.94 | N/A |
| P/B Ratio (TTM) | 0.51 | N/A |
| P/FCF Ratio (TTM) | 17.31 | N/A |
| Price to 5YR AVG Earnings Ratio | 4.30 | N/A |
| Price to 5YR AVG FCF Ratio | 3.67 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.43% | N/A |
| ROE (TTM) | 4.92% | N/A |
| Net Profit Margin (TTM) | 8.94% | N/A |
| ROIC 5YR AVG | 25.12% | N/A |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -22.02% | 37.87% | 18.57% |
| Revenue | 4.23% | 21.23% | 12.59% |
| Net Income | -22.07% | 37.76% | 18.50% |
| Cash Flow | 100.19% | 433.18% | 221.71% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.13 | N/A |
| Quick Ratio (TTM) | 0.13 | N/A |
| D/E Ratio (TTM) | 0.06 | N/A |
| Interest Coverage (TTM) | 1.40 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 0.43 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.07% | N/A |